Biography

Bhaskar is a Senior Advisor at Frazier Healthcare Partners, where he has served since 2011. He brings to the Life Sciences team significant operational experience in drug research, development and commercialization in the United States, Europe and emerging markets. He also leads investments in later-stage companies, as well as in international opportunities.

Prior to joining Frazier, Bhaskar was President of Valeant Pharmaceuticals, where he led the company’s international operations and business development activities. He joined Valeant through its acquisition of Dow Pharmaceutical Sciences, where he had been President and CEO. Before Dow, Bhaskar worked at Mylan Pharmaceuticals in several capacities, including EVP of Scientific Affairs at Bertek Pharmaceuticals, a Mylan subsidiary, and as General Manager of the Dermatology Division. Earlier, he worked at Penederm, a skincare and drug-delivery company, as VP of R&D.

Bhaskar co-founded Arcutis (NASDAQ: ARQT) and has served on multiple private and public company boards throughout his career. He is currently an advisor to the Johns Hopkins Berman Institute of Bioethics. Bhaskar holds a PhD in pharmaceutics, an MS in industrial pharmacy and a BS in pharmacy.